JP Morgan Maintains Neutral on Inspire Medical Systems, Raises Price Target to $60
JP Morgan analyst Robbie Marcus maintains Inspire Medical Systems (NYSE:INSP) with a Neutral and raises the price target from $54 to $60.
Read original at benzingaStocks · News reference
Inspire Medical Systems shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 guidance. Baird and Piper Sandler raised their respective price targets on the stock.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 4, 2026, 12:44 PM
- Checked
- Aug 4, 2026, 12:44 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Mizuho Maintains Outperform on Inspire Medical Systems, Raises Price Target to $65
Mizuho analyst Anthony Petrone maintains Inspire Medical Systems (NYSE:INSP) with a Outperform and raises the price target from $55 to $65.
Read original at benzingaOppenheimer Upgrades Inspire Medical Systems to Outperform, Announces $85 Price Target
Oppenheimer analyst Suraj Kalia upgrades Inspire Medical Systems (NYSE:INSP) from Perform to Outperform and announces $85 price target.
Read original at benzingaTruist Securities Reiterates Hold on Inspire Medical Systems, Raises Price Target to $62
Truist Securities analyst Richard Newitter reiterates Inspire Medical Systems (NYSE:INSP) with a Hold and raises the price target from $54 to $62.
Read original at benzinga